Skip to main content

Published locations for Choice of protease inhibitor may impact CVD risk in HIV+ patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Choice of protease inhibitor may impact CVD risk in HIV+ patients

User login

  • Reset your password
  • /content/choice-protease-inhibitor-may-impact-cvd-risk-hiv-patients
  • /familypracticenews/article/134824/hiv/choice-protease-inhibitor-may-impact-cvd-risk-hiv-patients
  • /idpractitioner/article/134824/hiv/choice-protease-inhibitor-may-impact-cvd-risk-hiv-patients
  • /internalmedicinenews/article/134824/hiv/choice-protease-inhibitor-may-impact-cvd-risk-hiv-patients
  • /ecardiologynews/article/134824/hiv/choice-protease-inhibitor-may-impact-cvd-risk-hiv-patients
  • /cardiology/article/134824/hiv/choice-protease-inhibitor-may-impact-cvd-risk-hiv-patients
  • /infectiousdisease/article/134824/hiv/choice-protease-inhibitor-may-impact-cvd-risk-hiv-patients
  • /internalmedicine/article/134824/hiv/choice-protease-inhibitor-may-impact-cvd-risk-hiv-patients
  • /familymedicine/article/134824/hiv/choice-protease-inhibitor-may-impact-cvd-risk-hiv-patients